isoxazoles has been researched along with avapro in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baska, RA; Beyer, SM; Carlson, KE; Dickinson, KE; Ewing, WR; Fadnis, L; Gu, Z; Humphreys, WG; Kowala, MC; Lan, SJ; Macor, JE; Monshizadegan, H; Murugesan, N; Tellew, JE; Valentine, MT; Yang, Y; Zahler, R | 1 |
1 other study(ies) available for isoxazoles and avapro
Article | Year |
---|---|
Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics.
Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Biological Availability; Biphenyl Compounds; Dogs; Endothelin A Receptor Antagonists; Humans; Hypertension; Irbesartan; Isoxazoles; Macaca fascicularis; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Structure-Activity Relationship; Sulfonamides; Tetrazoles | 2005 |